Abstract: A therapeutic composition comprising (i) at least one antigen or at least one in vivo generator of a compound comprising an amino acid sequence and (ii) at least one adjuvant comprising at least one pharmaceutically acceptable and water-soluble salt of an organic anion and a metal cation.

Abstract: A therapeutic composition comprising (i) at least one antigen or at least one in vivo generator of a compound comprising an amino acid sequence and (ii) at least one adjuvant comprising at least one pharmaceutically acceptable and water-soluble salt of an organic anion and a metal cation.

Abstract: The present invention relates to novel stable <<water-in-oil>> emulsions containing 5 to 70% by weight of an aqueous phase 20 to 90% by weight of a fatty phase; and 3 to 25% by weight of an emulsifier comprising 10 to 90% by weight, preferably 10 to 50% by weight and more preferably 10 to 40% by weight of a mixture in any proportion of an oleyl glycoside having a degree of polymerisation of between 1 and 3 and an isostearyl glycoside having a degree of polymerisation of between 1 and 3; and 90 to 10% by weight, preferably 90 to 50% by weight, and more preferably 90 to 60% by weight of a mixture in any proportion of oleyl alcohol and isostearyl alcohol and optionally 0 to 10% by weight of a co-emulsifier; 0 to 10% by weight of a stabiliser. Application: Cosmetic industry.

Abstract: The present invention relates to compositions based on alkyl polyglycosides and fatty alcohols, comprising:

Abstract: A thickener comprises a water-in-oil reverse emulsion and a copolymer having moieties derived (i) from a monounsaturated monocarboxylic acid monomer containing from 3 to 5 carbon atoms, the monocarboxylic acid either being in free form or in the form of an inorganic salt, and (ii) from a monoacrylamide monomer. The copolymer is in solution in the aqueous phase constituting the emulsion, the oil phase of this emulsion consisting of a mixture of at least one volatile oil and at least one non-volatile oil. The weight ratio between the volatile oil and the non-volatile oil is between 90/10 and 10/90. The oil phase represents from 10 to 60% by weight of the whole. Water represents from 30 to 70% by weight of the whole. The copolymer represents from 10 to 30% by weight of the whole and a surfactant represents from 5 to 20% by weight of the whole.

Abstract: An alkyl polyglycoside and fatty alcohol composition useful as an emulsifier includes: a) 8 to 40% by weight of an alkyl polyglycoside component consisting essentially of: 0 to 20% by weight of at least one alkyl polyglycoside of formula (I): R1O(G1)x1  (I)  in which R1 is a linear or branched alkyl radical having 16 or 18 carbon atoms, G1 is a saccharide residue and x1 is between 1 and 5; 0 to 100% by weight of an alkyl polyglycoside of formula (II): R2O(G2)2  (II)  in which R2 is a linear or branched alkyl radical having 14 carbon atoms, G2 is a saccharide residue and x2 is between 1 and 5; and 0 to 100% by weight of at least one alkyl polyglycoside of formula (III): R3O(G3)x3  (III)  in which R3 is a linear or branched alkyl radical having 20 or 22 carbon atoms, G3 is a saccharide residue and x3 is between 1 and 5; and b) 60 to 92% by weight of a linear or branched aliphatic alcohol having from 14 to 22 carbon atoms.

Abstract: A therapeutic composition comprising (i) at least one antigen or at least one in vivo generator of a compound comprising an amino acid sequence and (ii) at least one adjuvant comprising at least one pharmaceutically acceptable and water-soluble salt of an organic anion and a metal cation.

Abstract: A thickener comprises a water-in-oil reverse emulsion and a copolymer having moieties derived (i) from a monounsaturated monocarboxylic acid monomer containing from 3 to 5 carbon atoms, the monocarboxylic acid either being in free form or in the form of an inorganic salt, and (ii) from a monoacrylamide monomer. The copolymer is in solution in the aqueous phase constituting the emulsion, the oil phase of this emulsion consisting of a mixture of at least one volatile oil and at least one non-volatile oil. The weight ratio between the volatile oil and the non-volatile oil is between 90/10 and 10/90. The oil phase represents from 10 to 60% by weight of the whole. Water represents from 30 to 70% by weight of the whole. The copolymer represents from 10 to 30% by weight of the whole and a surfactant represents from 5 to 20% by weight of the whole.

Abstract: A therapeutic composition comprising (i) at least one antigen or at least one in vivo generator of a compound comprising an amino acid sequence and (ii) at least one adjuvant comprising at least one pharmaceutically acceptable and water-soluble salt of an organic anion and a trivalent metal cation.

Abstract: The present invention relates to the use of fatty alcohol based compositions comprising:60 to 90% by weight of at least one fatty alcohol having from 12 to 22 carbon atoms, preferably from 16 to 18 carbon atoms,10 to 40% by weight of an alkylpolyoside, preferably an alkylpolyoside of which the alkyl part is identical to that of the fatty alcohol,and, if appropriate, 0.5 to 5% of polyoside, for preparing emulsions.The invention finds an application in particular for preparing emulsions in the cosmetic and pharmaceutical fields.

Abstract: A concentrate that is particularly useful as a pearling agent or for preparing emulsions is provided. The concentrate includes from 60 to 90% by weight of a mixture of at least one alkylglycoside of the formula RO(G).sub.x and of at least one alkylglycoside of the formula R'O(G').sub.x '. R represents a saturated or unsaturated linear or branched aliphatic radical containing from 8 to 15 carbon atoms. R' represents a saturated or unsaturated linear or branched aliphatic radical containing from 16 to 22 carbon atoms. G and G', which are identical or different, represent a saccharide residue. The subscripts x and x', which are identical or different, represent a number between 1 and 10. The concentrate also includes from 10 to 40% by weight of at least one fatty alcohol of the formula R.sub.1 OH, R.sub.1 being a saturated or unsaturated linear or branched aliphatic radical containing from 8 to 22 carbon atoms.

Abstract: The present invention relates to injectable multi-phase solutions of W/O/W type, usable as vaccines or as vehicles of active substances in human and veterinary medicine, which are pharmaceutically acceptable in each one of their constituents, stable for at least 12 months in storage at 4.degree. C., of viscosity less than 300 mPas and comprise at least the following constituents:an oily adjuvant composed of:a water-immiscible oily phase representing between 20 and 70% of the formula,an emulsifying system selected so that the inversion point of the resulting emulsion ranges between 25.degree. and 45.degree. and represents between 2 and 10% of the formula,an aqueous phase containing the antigens or the active substances and representing between 20 and 78% of the formula and obtained in a single mixing operation.

Abstract: The present invention relates to an injectable emulsion, usable as a vaccine or active principle vehicle, which has an oily continuous phase with a good tolerance under normal conditions of injection into a human or an animal, said emulsion being characterized by a viscosity of less than 800 mPas at 20.degree. C. and consisting of at least20 to 90% of an oily adjuvant which is liquid at 4.degree. C. and contains at leastone or more appropriate and pharmaceutically acceptable emulsifiers anda mixture, in any proportions, of one or more metabolizable oils with one or more non-metabolizable oils, and10 to 80% of a hydrophilic phase containing the active principles or antigens.

Abstract: The present invention relates to a film-forming product for coating solid forms, to a process for the manufacture of this film-forming product and to products coated with this film-forming product. According to the invention, this film-forming product takes the form of homogeneous granular particles which can easily be dispersed in an aqueous or organic solvent and which make it possible to obtain a uniform non-matt film, and its dry matter comprises:at least one ingestible, non-toxic film-forming substance in an amount of between 30 and 95% by weight;at least one colored pigment in an amount of between 5 and 50% by weight; andif appropriate, at least one edible plasticizer in an amount less than or equal to 30% by weight.

Abstract: The present invention relates to a process for the preparation of grains of starch, which comprises granulating a mixture obtained by spraying 1 to 20%, and preferably 2 to 6% by weight, of a starch paste obtained from native starch under mild conditions, on to 99 to 80% by weight of grains of native starch, and drying, grinding and sieving the resulting product to give aggregates (grains) having a mean particle size of between 100 and about 500 .mu.m.

Abstract: The present invention relates to a novel desiccant powder and its use for the drying of solid substrates wetted by an aqueous or oily liquid such as, in particular, grains or seeds having undergone a coating or surface film-forming treatment.According to the invention, this desiccant powder contains at least 50% by weight of absorbents with respect to the toal weight of the said powder, being preferably available in the form of particles having a mean diameter less than about 100.mu., the said absorbents being constituted of at least one aluminosilicate, in particular mica, to at least 25% by weight with respect to the total weight of the said absorbents.This powder makes possible, in particular, the drying of colored grains or seeds.